Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Graham Schwarz

Plastic and Reconstructive Surgery New York, NY Medical Doctor

NPI 1043478886 CMS profile 274647

525 E 68Th St, Weill Cornell Medical Ctr Div Of Plastic Surgery K707, New York, NY 10065

Open in the dashboard

General payments

$16,274

74 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$109,000 paid to institutions, not to them · program years 2024–2025

Through program year 2025, Graham Schwarz of New York, NY is reported in the CMS Open Payments database as having received $16,274 across 74 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $109,000 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 88th percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,324 10
2024 General $4,045 19
2023 General $1,572 19
2022 General $3,472 10
2021 General $3,409 7
2020 General $1,205 4
2019 General $248 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Graham Schwarz
  • Plastic and Reconstructive Surgery median
  • Middle half of Plastic and Reconstructive Surgery
  • National median

In program year 2025, general payments to Graham Schwarz were reported at $2,324. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.

Show as a table
Year Graham Schwarz Plastic and Reconstructive Surgery median Middle half National median
2019 $248 $335 $121–$1,264 $163
2020 $1,205 $162 $57–$417 $114
2021 $3,409 $245 $89–$735 $132
2022 $3,472 $325 $120–$932 $149
2023 $1,572 $343 $129–$999 $160
2024 $4,045 $390 $141–$1,085 $164
2025 $2,324 $442 $150–$1,242 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. RTI Surgical, Inc $4,040 4 payments
  2. ImpediMed, Inc. $3,000 2 payments
  3. Surgical Innovation Associates, Inc. $1,500 1 payment
  4. Quest Medical Imaging, Inc $1,000 2 payments
  5. AxoGen $959 10 payments
  6. Becton, Dickinson and Company $934 1 payment
  7. Integra LifeSciences Corporation $531 8 payments
  8. Davol Inc. $450 1 payment
  9. AbbVie, Inc. $419 7 payments
  10. TELA Bio, Inc. $346 2 payments
  11. Other $3,095 36 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Honoraria $6,900 5 payments
  2. Food and Beverage $5,490 64 payments
  3. Consulting Fee $3,434 4 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $450 1 payment
Products named General payments · program years 2019–2025
  1. CORTIVA ALLOGRAFT DERMIS $3,900 3 payments
  2. DuraSorb Monofilament Mesh $1,500 1 payment
  3. Avance Nerve Graft $808 7 payments
  4. Integra Recon-Skin And Wound $531 8 payments
  5. Integra Recon-Skin And Wound $531 8 payments
  6. INTEGRA DERMAL REGENERATION TEMPLATE $531 8 payments
  7. AxoGuard Nerve Connector $393 6 payments
  8. AXOGUARD NERVE PROTECTOR $393 6 payments
  9. OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) $346 2 payments
  10. GORE ENFORM Preperitoneal Biomaterial $344 2 payments
  11. Other $5,380 76 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 31 billing codes

Paid by Medicare

$24,119

Medicare's payments for the services billed

Medicare patients

70

Average age 71

Services billed

126

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 64%
Cancer 63%
Arthritis 54%
Osteoporosis 36%
Diabetes 20%
Depression 17%
Alzheimer's or dementia 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

74 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic and Reconstructive Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record